Log In
BCIQ
Print this Print this
 

lesinurad + allopurinol FDC

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionFixed does combination of lesinurad, a solute carrier family 22 organic anion urate transporter member 12 (SLC22A12; URAT1) inhibitor and allopurinol, a xanthine oxidase inhibitor
Molecular Target Solute carrier family 22 organic anion urate transporter member 12 (SLC22A12) (URAT1)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationHyperuricemia / gout
Indication DetailsTreat hyperuricemia in patients with gout
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today